Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces
Open Access
- 17 July 2010
- journal article
- Published by Springer Nature in BMC Health Services Research
- Vol. 10 (1) , 211
Abstract
The current health care reform in China launched in 2009 tackles the problem of access to appropriate medicines for its 1.3 billion people by focusing on providing essential medicines to all. To provide evidence for the reform process, we investigated the manufacturing, purchasing, and prescribing of essential medicines in two provinces.Keywords
This publication has 10 references indexed in Scilit:
- China's growing biomedical industryBiologicals, 2009
- Reform of how health care is paid for in China: challenges and opportunitiesThe Lancet, 2008
- Pharmaceutical Policy In ChinaHealth Affairs, 2008
- Issues in Drug Pricing, Reimbursement, and Access in China with References to Other Asia-Pacific RegionValue in Health, 2008
- Health service delivery in China: a literature reviewHealth Economics, 2007
- The impact of China's retail drug price control policy on hospital expenditures: a case study in two Shandong hospitalsHealth Policy and Planning, 2005
- Addressing government and market failures with payment incentives: Hospital reimbursement reform in Hainan, ChinaSocial Science & Medicine, 2004
- 25 years of the WHO essential medicines lists: progress and challengesThe Lancet, 2003
- Association between health insurance and antibiotics prescribing in four counties in rural ChinaHealth Policy, 1999
- Drug Prescribing in Rural Health Facilities in China: Implications for Service Quality and CostTropical Doctor, 1998